Abdullatif Al Khal

4.8k total citations · 1 hit paper
20 papers, 1.0k citations indexed

About

Abdullatif Al Khal is a scholar working on Infectious Diseases, Epidemiology and Modeling and Simulation. According to data from OpenAlex, Abdullatif Al Khal has authored 20 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Infectious Diseases, 7 papers in Epidemiology and 4 papers in Modeling and Simulation. Recurrent topics in Abdullatif Al Khal's work include SARS-CoV-2 and COVID-19 Research (12 papers), COVID-19 Clinical Research Studies (7 papers) and COVID-19 epidemiological studies (4 papers). Abdullatif Al Khal is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (12 papers), COVID-19 Clinical Research Studies (7 papers) and COVID-19 epidemiological studies (4 papers). Abdullatif Al Khal collaborates with scholars based in Qatar, United States and United Kingdom. Abdullatif Al Khal's co-authors include Hamad Eid Al‐Romaihi, Elmoubasher Farag, Adeel A. Butt, Salih Al-Marri, Peter Coyle, Mohamed H. Al‐Thani, Gert‐Jan Godeke, Marcel Jonges, Mohd M. AlHajri and V. Stalin Raj and has published in prestigious journals such as SHILAP Revista de lepidopterología, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Abdullatif Al Khal

19 papers receiving 1.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation

2013 503 citations Bart L. Haagmans, Chantal Reusken et al. The Lancet Infectious Diseases profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Abdullatif Al Khal Qatar	14	814	210	201	175	86	20	1.0k
Wan-Mui Chan Hong Kong	16	1.1k 1.4×	85 0.4×	173 0.9×	128 0.7×	103 1.2×	26	1.4k
Raafat F. Alhakeem Saudi Arabia	14	771 0.9×	177 0.8×	238 1.2×	233 1.3×	34 0.4×	17	986
Sylvie Behillil France	17	598 0.7×	161 0.8×	173 0.9×	388 2.2×	38 0.4×	27	1.1k
Wing‐Kin To China	14	789 1.0×	49 0.2×	152 0.8×	210 1.2×	101 1.2×	22	1.0k
Nadhira Houhou‐Fidouh France	13	1.2k 1.5×	65 0.3×	109 0.5×	351 2.0×	131 1.5×	24	1.6k
Sami Al Hajjar Saudi Arabia	10	545 0.7×	135 0.6×	134 0.7×	280 1.6×	23 0.3×	14	752
Farida Al Hosani United Arab Emirates	11	418 0.5×	94 0.4×	74 0.4×	65 0.4×	89 1.0×	18	591
Katherine A. Twohig United Kingdom	8	555 0.7×	36 0.2×	192 1.0×	80 0.5×	67 0.8×	17	855
Ignacio Torres Spain	16	646 0.8×	76 0.4×	74 0.4×	270 1.5×	39 0.5×	55	938
Varsha Potdar India	19	940 1.2×	111 0.5×	203 1.0×	757 4.3×	54 0.6×	79	1.6k

Countries citing papers authored by Abdullatif Al Khal

Since Specialization

Citations

This map shows the geographic impact of Abdullatif Al Khal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Abdullatif Al Khal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Abdullatif Al Khal more than expected).

Fields of papers citing papers by Abdullatif Al Khal

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Abdullatif Al Khal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Abdullatif Al Khal. The network helps show where Abdullatif Al Khal may publish in the future.

Co-authorship network of co-authors of Abdullatif Al Khal

This figure shows the co-authorship network connecting the top 25 collaborators of Abdullatif Al Khal. A scholar is included among the top collaborators of Abdullatif Al Khal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Abdullatif Al Khal. Abdullatif Al Khal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Khoodoruth, Mohamed Adil Shah, et al.. (2023). The Impact of Multisource Feedback on Continuing Medical Education, Clinical Performance and Patient Experience: Innovation in a Child and Adolescent Mental Health Service. PubMed. 12(1). 2202834–2202834.

Abu‐Raddad, Laith J., Soha R. Dargham, Hiam Chemaitelly, et al.. (2022). COVID-19 risk score as a public health tool to guide targeted testing: A demonstration study in Qatar. PLoS ONE. 17(7). e0271324–e0271324. 1 indexed citations

Butt, Adeel A., Soha R. Dargham, Riyazuddin Mohammad Shaik, et al.. (2022). Coronavirus Disease 2019 Disease Severity in Children Infected With the Omicron Variant. Clinical Infectious Diseases. 75(1). e361–e367. 80 indexed citations

Bansal, Devendra, Jazeel Abdulmajeed, Sayed Himatt, et al.. (2022). Duration of COVID-19 mRNA Vaccine Effectiveness against Severe Disease. Vaccines. 10(7). 1036–1036. 2 indexed citations

Butt, Adeel A., Soha R. Dargham, Patrick Tang, et al.. (2022). COVID-19 disease severity in persons infected with the Omicron variant compared with the Delta variant in Qatar. Journal of Global Health. 12. 5032–5032. 31 indexed citations

Daghfal, Joanne, et al.. (2022). The Role of Post-Bronchoscopy Sputum Examination in Screening for Active Tuberculosis. Tropical Medicine and Infectious Disease. 8(1). 13–13. 5 indexed citations

Ayoub, Houssein H., Hiam Chemaitelly, Monia Makhoul, et al.. (2021). Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses. BMJ Innovations. 7(2). 327–336. 17 indexed citations

Hasan, Mohammad R., Sathyavathi Sundararaju, Anju Sharma, et al.. (2021). Real-Time SARS-CoV-2 Genotyping by High-Throughput Multiplex PCR Reveals the Epidemiology of the Variants of Concern in Qatar. International Journal of Infectious Diseases. 112. 52–54. 20 indexed citations

Butt, Adeel A., Hanaa Nafady‐Hego, Hiam Chemaitelly, et al.. (2021). Outcomes Among Patients with Breakthrough SARS-CoV-2 Infection After Vaccination. International Journal of Infectious Diseases. 110. 353–358. 63 indexed citations

10.

Seedat, Shaheen, Hiam Chemaitelly, Houssein H. Ayoub, et al.. (2021). SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar. Scientific Reports. 11(1). 18182–18182. 13 indexed citations

11.

Ayoub, Houssein H., Hiam Chemaitelly, Shaheen Seedat, et al.. (2021). Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19. Journal of Global Health. 11. 5005–5005. 17 indexed citations

12.

Butt, Adeel A., Soha R. Dargham, Hiam Chemaitelly, et al.. (2021). Severity of Illness in Persons Infected With the SARS-CoV-2 Delta Variant vs Beta Variant in Qatar. JAMA Internal Medicine. 182(2). 197–197. 66 indexed citations

13.

Khal, Abdullatif Al, et al.. (2020). Qatar's response to COVID-19 pandemic. SHILAP Revista de lepidopterología. 21(3). 129–129. 22 indexed citations

14.

Rahim, Hanan F. Abdul, Laith J. Abu‐Raddad, Abdul‐Badi Abou‐Samra, et al.. (2020). Epidemiological investigation of the first 5685 cases of SARS-CoV-2 infection in Qatar, 28 February–18 April 2020. BMJ Open. 10(10). e040428–e040428. 54 indexed citations

15.

Al‐Romaihi, Hamad Eid, Maria K. Smatti, Hebah A. Al-Khatib, et al.. (2020). Molecular epidemiology of influenza, RSV, and other respiratory infections among children in Qatar: A six years report (2012–2017). International Journal of Infectious Diseases. 95. 133–141. 26 indexed citations

16.

Zaqout, Ahmed, Khaled Murshed, Issam Al‐Bozom, et al.. (2019). Cerebral schistosomiasis: Case series from Qatar. International Journal of Infectious Diseases. 86. 167–170. 11 indexed citations

17.

Al‐Romaihi, Hamad Eid, Maria K. Smatti, Elmoubasher Farag, et al.. (2019). Epidemiology of respiratory infections among adults in Qatar (2012-2017). PLoS ONE. 14(6). e0218097–e0218097. 22 indexed citations

18.

Abukhattab, Mohammed, et al.. (2018). Epidemiology and clinical outcomes of viral central nervous system infections. International Journal of Infectious Diseases. 73. 85–90. 39 indexed citations

19.

Butt, Adeel A., et al.. (2016). Antibiotic prescription patterns for upper respiratory tract infections in the outpatient Qatari population in the private sector. International Journal of Infectious Diseases. 55. 20–23. 35 indexed citations

20.

Haagmans, Bart L., Chantal Reusken, V. Stalin Raj, et al.. (2013). Middle East respiratory syndrome coronavirus in dromedary camels: an outbreak investigation. The Lancet Infectious Diseases. 14(2). 140–145. 503 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact